Last --
Change Today 0.00 / 0.00%
Volume 0.0
4559 On Other Exchanges
Symbol
Exchange
4559 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

zeria pharmaceutical co ltd (4559) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ZERIA PHARMACEUTICAL CO LTD (4559)

Related News

No related news articles were found.

zeria pharmaceutical co ltd (4559) Related Businessweek News

No Related Businessweek News Found

zeria pharmaceutical co ltd (4559) Details

Zeria Pharmaceutical Co., Ltd. manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents. The company also provides cosmetics, health foods, alcoholic beverages, carbonated beverages, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, measuring equipment, and analytical equipment. Its ethical pharmaceutical products include functional dyspepsia treatment products, histamine h2 receptor antagonists, zinc containing anti-ulcerants, oral bowel cleansing products, laxative products, ulcerative colitis remedies, and proton pump inhibitors in the gastrointestinal field. The company’s products also include hypophosphatemia treatment products, long-acting calcium channel blockers, absorbable topical hemostats, sclerotherapy products for leg varicose veins, enzymatic hemostatics, anti-platelet oral jellies, oral non-steroidal anti-inflammatory products, anti-leukopenia after radiotherapy products, topical non-steroidal anti-inflammatory products, anti-inflammatory topical blood circulation enhancers, and non-steroidal anti-inflammatory ophthalmic solutions. In addition, Zeria Pharmaceutical Co., Ltd. offers OTC drugs and products, such as self-prevention products, remedies for gastrointestinal diseases, dermal remedies/cosmeceuticals, ophthalmic solutions, cold remedies, nutrient tonics, and topical anti-inflammatory analgesics. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.

1,426 Employees
Last Reported Date: 06/26/15
Founded in 1955

zeria pharmaceutical co ltd (4559) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zeria pharmaceutical co ltd (4559) Key Developments

Zeria Pharmaceutical Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended Dec. 31, 2015; Provides Dividend Guidance for the Year Ending March 31, 2016; Provides Earnings Guidance for the Year Ending March 31, 201

Zeria Pharmaceutical Co., Ltd. announced consolidated earnings results for the nine months ended Dec. 31, 2015. For the period, the company reported net sales of JPY 47,054 million, operating income of JPY 3,792 million, profit attributable to owners of parent of JPY 3,335 million or JPY 62.79 per share compared to net sales of JPY 45,782 million, operating income was JPY 3,340 million, profit attributable to owners of parent was JPY 3,160 million or JPY 59.50 per share for the same period a year ago. The company provided dividend guidance for the year ending March 31, 2016. For the year end, the company expects to pay dividend of JPY 15 compared to JPY 15 per share paid a year ago. The company provided consolidated earnings guidance for the full year ending March 31, 2016. For the full year, the company expects net sales of JPY 65,000 million, operating income of JPY 4,500 million, profit attributable to owners of parent of JPY 3,300 million or JPY 62.13 per share.

Zeria Pharmaceutical Co., Ltd. to Report Q3, 2016 Results on Feb 04, 2016

Zeria Pharmaceutical Co., Ltd. announced that they will report Q3, 2016 results on Feb 04, 2016

Zeria Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter of Fiscal 2016, Payable on December 1, 2015; Provides Dividend Guidance for the Year End of Fiscal 2016; Announces Consolidated Earnings Results for the Six Months Ended Sep. 30, 2015; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2016

Zeria Pharmaceutical Co., Ltd. announced dividend for the second quarter of fiscal 2016. For the second quarter, the company announced dividend of JPY 15 per share compared to JPY 15 per share paid a year ago. Scheduled date to commencement of dividend payments is on December 1, 2015. The company provided dividend guidance for the year end of fiscal 2016. For the year end, the company expects to pay dividend of JPY 15 compared to JPY 15 per share paid a year ago. Zeria Pharmaceutical Co., Ltd. announced consolidated earnings results for the six months ended Sep. 30, 2015. For the period, the company reported net sales of JPY 30,343 million, operating income was JPY 2,114 million, ordinary income of JPY 1,584 million and profit attributable to owners of parent was JPY 1,616 million or JPY 30.44 per share compared to net sales of JPY 30,136 million, operating income was JPY 2,279 million, ordinary income of JPY 2,240 million and profit attributable to owners of parent was JPY 2,115 million or JPY 39.83 per share for the same period a year ago. The company provided consolidated earnings guidance for the full year ending March 31, 2016. For the full year, the company expects net sales of JPY 65,000 million, operating income was JPY 4,500 million, ordinary income of JPY 4,100 million and profit attributable to owners of parent was JPY 3,300 million or JPY 62.13 per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4559:JP ¥1,380.00 JPY -21.00

4559 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4559.
View Industry Companies
 

Industry Analysis

4559

Industry Average

Valuation 4559 Industry Range
Price/Earnings 29.9x
Price/Sales 1.3x
Price/Book 1.3x
Price/Cash Flow 29.9x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ZERIA PHARMACEUTICAL CO LTD, please visit www.zeria.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.